Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.
Identifieur interne : 002241 ( PubMed/Checkpoint ); précédent : 002240; suivant : 002242Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.
Auteurs : A P T. Van Der Ploeg [Pays-Bas] ; A C J. Van Akkooi ; P I M. Schmitz ; A N Van Geel ; J H De Wilt ; A M M. Eggermont ; C. VerhoefSource :
- Annals of surgical oncology [ 1534-4681 ] ; 2011.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aine (), Aine (anatomopathologie), Femelle, Humains, Jeune adulte, Lymphadénectomie, Mâle, Mélanome (), Mélanome (anatomopathologie), Mélanome (mortalité), Métastase lymphatique, Pronostic, Récidive tumorale locale (), Récidive tumorale locale (anatomopathologie), Récidive tumorale locale (mortalité), Sujet âgé, Sujet âgé de 80 ans ou plus, Taux de survie, Tumeurs cutanées (), Tumeurs cutanées (mortalité), Tumeurs cutanées (secondaire), Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Aine, Mélanome, Récidive tumorale locale.
- mortalité : Mélanome, Récidive tumorale locale, Tumeurs cutanées.
- secondaire : Tumeurs cutanées.
- Adulte, Adulte d'âge moyen, Aine, Femelle, Humains, Jeune adulte, Lymphadénectomie, Mâle, Mélanome, Métastase lymphatique, Pronostic, Récidive tumorale locale, Sujet âgé, Sujet âgé de 80 ans ou plus, Taux de survie, Tumeurs cutanées, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Groin (pathology), Groin (surgery), Humans, Lymph Node Excision, Lymphatic Metastasis, Male, Melanoma (mortality), Melanoma (pathology), Melanoma (surgery), Middle Aged, Neoplasm Recurrence, Local (mortality), Neoplasm Recurrence, Local (pathology), Neoplasm Recurrence, Local (surgery), Prognosis, Retrospective Studies, Skin Neoplasms (mortality), Skin Neoplasms (secondary), Skin Neoplasms (surgery), Survival Rate, Young Adult.
- MESH :
- mortality : Melanoma, Neoplasm Recurrence, Local, Skin Neoplasms.
- pathology : Groin, Melanoma, Neoplasm Recurrence, Local.
- secondary : Skin Neoplasms.
- surgery : Groin, Melanoma, Neoplasm Recurrence, Local, Skin Neoplasms.
- Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Lymph Node Excision, Lymphatic Metastasis, Male, Middle Aged, Prognosis, Retrospective Studies, Survival Rate, Young Adult.
Abstract
Management of patients with clinically detectable lymph node metastasis to the groin is by ilioinguinal or combined superficial and deep groin dissection (CGD) according to most literature, but in practice superficial groin dissection (SGD) only is still performed in some centers. The aim of this study is to evaluate the experience in CGD versus SGD patients in our center.
DOI: 10.1245/s10434-011-1741-0
PubMed: 21537867
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:21537867Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.</title><author><name sortKey="Van Der Ploeg, A P T" sort="Van Der Ploeg, A P T" uniqKey="Van Der Ploeg A" first="A P T" last="Van Der Ploeg">A P T. Van Der Ploeg</name><affiliation wicri:level="3"><nlm:affiliation>Department of Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Van Akkooi, A C J" sort="Van Akkooi, A C J" uniqKey="Van Akkooi A" first="A C J" last="Van Akkooi">A C J. Van Akkooi</name></author><author><name sortKey="Schmitz, P I M" sort="Schmitz, P I M" uniqKey="Schmitz P" first="P I M" last="Schmitz">P I M. Schmitz</name></author><author><name sortKey="Van Geel, A N" sort="Van Geel, A N" uniqKey="Van Geel A" first="A N" last="Van Geel">A N Van Geel</name></author><author><name sortKey="De Wilt, J H" sort="De Wilt, J H" uniqKey="De Wilt J" first="J H" last="De Wilt">J H De Wilt</name></author><author><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A M M" last="Eggermont">A M M. Eggermont</name></author><author><name sortKey="Verhoef, C" sort="Verhoef, C" uniqKey="Verhoef C" first="C" last="Verhoef">C. Verhoef</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21537867</idno><idno type="pmid">21537867</idno><idno type="doi">10.1245/s10434-011-1741-0</idno><idno type="wicri:Area/PubMed/Corpus">002643</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002643</idno><idno type="wicri:Area/PubMed/Curation">002643</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002643</idno><idno type="wicri:Area/PubMed/Checkpoint">002643</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002643</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.</title><author><name sortKey="Van Der Ploeg, A P T" sort="Van Der Ploeg, A P T" uniqKey="Van Der Ploeg A" first="A P T" last="Van Der Ploeg">A P T. Van Der Ploeg</name><affiliation wicri:level="3"><nlm:affiliation>Department of Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Van Akkooi, A C J" sort="Van Akkooi, A C J" uniqKey="Van Akkooi A" first="A C J" last="Van Akkooi">A C J. Van Akkooi</name></author><author><name sortKey="Schmitz, P I M" sort="Schmitz, P I M" uniqKey="Schmitz P" first="P I M" last="Schmitz">P I M. Schmitz</name></author><author><name sortKey="Van Geel, A N" sort="Van Geel, A N" uniqKey="Van Geel A" first="A N" last="Van Geel">A N Van Geel</name></author><author><name sortKey="De Wilt, J H" sort="De Wilt, J H" uniqKey="De Wilt J" first="J H" last="De Wilt">J H De Wilt</name></author><author><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A M M" last="Eggermont">A M M. Eggermont</name></author><author><name sortKey="Verhoef, C" sort="Verhoef, C" uniqKey="Verhoef C" first="C" last="Verhoef">C. Verhoef</name></author></analytic><series><title level="j">Annals of surgical oncology</title><idno type="eISSN">1534-4681</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Follow-Up Studies</term><term>Groin (pathology)</term><term>Groin (surgery)</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphatic Metastasis</term><term>Male</term><term>Melanoma (mortality)</term><term>Melanoma (pathology)</term><term>Melanoma (surgery)</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local (mortality)</term><term>Neoplasm Recurrence, Local (pathology)</term><term>Neoplasm Recurrence, Local (surgery)</term><term>Prognosis</term><term>Retrospective Studies</term><term>Skin Neoplasms (mortality)</term><term>Skin Neoplasms (secondary)</term><term>Skin Neoplasms (surgery)</term><term>Survival Rate</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aine ()</term><term>Aine (anatomopathologie)</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Lymphadénectomie</term><term>Mâle</term><term>Mélanome ()</term><term>Mélanome (anatomopathologie)</term><term>Mélanome (mortalité)</term><term>Métastase lymphatique</term><term>Pronostic</term><term>Récidive tumorale locale ()</term><term>Récidive tumorale locale (anatomopathologie)</term><term>Récidive tumorale locale (mortalité)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Taux de survie</term><term>Tumeurs cutanées ()</term><term>Tumeurs cutanées (mortalité)</term><term>Tumeurs cutanées (secondaire)</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Aine</term><term>Mélanome</term><term>Récidive tumorale locale</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Melanoma</term><term>Neoplasm Recurrence, Local</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Mélanome</term><term>Récidive tumorale locale</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Groin</term><term>Melanoma</term><term>Neoplasm Recurrence, Local</term></keywords><keywords scheme="MESH" qualifier="secondaire" xml:lang="fr"><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Groin</term><term>Melanoma</term><term>Neoplasm Recurrence, Local</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphatic Metastasis</term><term>Male</term><term>Middle Aged</term><term>Prognosis</term><term>Retrospective Studies</term><term>Survival Rate</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aine</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Lymphadénectomie</term><term>Mâle</term><term>Mélanome</term><term>Métastase lymphatique</term><term>Pronostic</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Taux de survie</term><term>Tumeurs cutanées</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Management of patients with clinically detectable lymph node metastasis to the groin is by ilioinguinal or combined superficial and deep groin dissection (CGD) according to most literature, but in practice superficial groin dissection (SGD) only is still performed in some centers. The aim of this study is to evaluate the experience in CGD versus SGD patients in our center.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21537867</PMID><DateCreated><Year>2011</Year><Month>10</Month><Day>13</Day></DateCreated><DateCompleted><Year>2012</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-4681</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>12</Issue><PubDate><Year>2011</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of surgical oncology</Title><ISOAbbreviation>Ann. Surg. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.</ArticleTitle><Pagination><MedlinePgn>3300-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1245/s10434-011-1741-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Management of patients with clinically detectable lymph node metastasis to the groin is by ilioinguinal or combined superficial and deep groin dissection (CGD) according to most literature, but in practice superficial groin dissection (SGD) only is still performed in some centers. The aim of this study is to evaluate the experience in CGD versus SGD patients in our center.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Between 1991 and 2009, 121 therapeutic CGD and 48 SGD were performed in 169 melanoma patients with palpable groin metastases at our institute. Median follow-up was 20 and, for survivors, 45 months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this heterogeneous group of patients, overall (OS) and disease-free survival, local control rates, and morbidity rates were not significantly different between CGD and SGD patients. However, CGD patients had a trend towards more chronic lymphedema. Superficial lymph node ratio, the number of positive superficial lymph nodes, and the presence of deep nodes were prognostic factors for survival. CGD patients with involved deep lymph nodes (24.8%) had estimated 5-year OS of 12% compared with 40% with no involved deep lymph nodes (p=0.001). Preoperative computed tomography (CT) scan had high negative predictive value of 91% for detection of pelvic nodal involvement.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study demonstrated that survival and local control do not differ for patients with palpable groin metastases treated by CGD or SGD. Patients without pathological iliac nodes on CT might safely undergo SGD, while CGD might be reserved for patients with multiple positive nodes on SGD and/or positive deep nodes on CT scan.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Ploeg</LastName><ForeName>A P T</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Akkooi</LastName><ForeName>A C J</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Schmitz</LastName><ForeName>P I M</ForeName><Initials>PI</Initials></Author><Author ValidYN="Y"><LastName>van Geel</LastName><ForeName>A N</ForeName><Initials>AN</Initials></Author><Author ValidYN="Y"><LastName>de Wilt</LastName><ForeName>J H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Eggermont</LastName><ForeName>A M M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Verhoef</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg Oncol</MedlineTA><NlmUniqueID>9420840</NlmUniqueID><ISSNLinking>1068-9265</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Surg Gynecol Obstet. 1992 Mar;174(3):195-200</RefSource><PMID Version="1">1542834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 1989 Feb;124(2):162-6</RefSource><PMID Version="1">2464981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2011 Jan;253(1):109-15</RefSource><PMID Version="1">21119509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2011 Apr;18(4):970-6</RefSource><PMID Version="1">21153883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1994 Dec;81(12):1771-4</RefSource><PMID Version="1">7827936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 1994 Jul;1(4):271-7</RefSource><PMID Version="1">7850524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1995 Aug;82(8):1057-9</RefSource><PMID Version="1">7648153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 1996 Apr;171(4):421-2</RefSource><PMID Version="1">8604834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 1999 Apr-May;6(3):230-1</RefSource><PMID Version="1">10340880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 1999 Apr-May;6(3):255-62</RefSource><PMID Version="1">10340884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 1999 Apr-May;6(3):263-71</RefSource><PMID Version="1">10340885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2007 Oct;14(10):2867-75</RefSource><PMID Version="1">17671814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2008 Aug;248(2):286-93</RefSource><PMID Version="1">18650640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ANZ J Surg. 2008 Nov;78(11):982-6</RefSource><PMID Version="1">18959697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2009 Jun 1;115(11):2384-7</RefSource><PMID Version="1">19306419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2009 Jun 1;115(11):2505-13</RefSource><PMID Version="1">19309746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Dec 20;27(36):6199-206</RefSource><PMID Version="1">19917835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 May 10;28(14):2452-9</RefSource><PMID Version="1">20368546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2010 Dec;17(12):3324-9</RefSource><PMID Version="1">20614193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1999 Dec;86(12):1493-8</RefSource><PMID Version="1">10594495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 2000 Jul;87(7):892-901</RefSource><PMID Version="1">10931025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2001;40(1):72-8</RefSource><PMID Version="1">11321665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2002 Jun;28(4):424-30</RefSource><PMID Version="1">12099654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2004 Jul 1;86(4):189-99</RefSource><PMID Version="1">15221926</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 1974 Feb;179(2):156-9</RefSource><PMID Version="1">4811045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 1982 Aug;196(2):180-6</RefSource><PMID Version="1">7092368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 1986 Nov;152(5):491-5</RefSource><PMID Version="1">3777327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Gynecol Obstet. 1988 Jul;167(1):28-32</RefSource><PMID Version="1">3289133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1993 Dec 1;72(11):3248-52</RefSource><PMID Version="1">8242549</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006119" MajorTopicYN="N">Groin</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="Y">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3192282</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21537867</ArticleId><ArticleId IdType="doi">10.1245/s10434-011-1741-0</ArticleId><ArticleId IdType="pmc">PMC3192282</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country><region><li>Hollande-Méridionale</li></region><settlement><li>Rotterdam</li></settlement></list><tree><noCountry><name sortKey="De Wilt, J H" sort="De Wilt, J H" uniqKey="De Wilt J" first="J H" last="De Wilt">J H De Wilt</name><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A M M" last="Eggermont">A M M. Eggermont</name><name sortKey="Schmitz, P I M" sort="Schmitz, P I M" uniqKey="Schmitz P" first="P I M" last="Schmitz">P I M. Schmitz</name><name sortKey="Van Akkooi, A C J" sort="Van Akkooi, A C J" uniqKey="Van Akkooi A" first="A C J" last="Van Akkooi">A C J. Van Akkooi</name><name sortKey="Van Geel, A N" sort="Van Geel, A N" uniqKey="Van Geel A" first="A N" last="Van Geel">A N Van Geel</name><name sortKey="Verhoef, C" sort="Verhoef, C" uniqKey="Verhoef C" first="C" last="Verhoef">C. Verhoef</name></noCountry><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Van Der Ploeg, A P T" sort="Van Der Ploeg, A P T" uniqKey="Van Der Ploeg A" first="A P T" last="Van Der Ploeg">A P T. Van Der Ploeg</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002241 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002241 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:21537867
|texte= Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:21537867" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |